- Report
- October 2025
- 184 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- October 2025
- 181 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- October 2025
- 194 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- August 2025
- 199 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- August 2025
- 192 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- August 2025
- 188 Pages
Global
From €3495EUR$3,939USD£3,026GBP
- Report
- January 2026
- 383 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- January 2026
- 281 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- January 2026
- 474 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- January 2026
- 278 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- January 2026
- 265 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- January 2026
- 282 Pages
Global
From €5191EUR$5,850USD£4,494GBP
- Report
- October 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- September 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- August 2025
- 250 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- July 2025
- 175 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- April 2025
- 175 Pages
Global
From €3984EUR$4,490USD£3,449GBP
- Report
- April 2025
- 175 Pages
Global
From €3984EUR$4,490USD£3,449GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more